Stock & Company Details
Cardiol Therapeutics Inc $CRDL
Price:
N/A
N/A
119M
$158M
52 Week High:
N/A
10 Day Average Volume:
N/A
-3.32
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
CRDL technical indicators
Latest Cardiol Therapeutics Inc (CRDL) indicator readings as of 2026-10-09.
CRDL's 14-day RSI is 22.3, in oversold territory. At $1.23 it is trading 4.8% below its 200-day moving average of $1.29, and below its 50-day average of $1.75. Price sits near the lower Bollinger Band ($1.17 to $2.12). ADX reads 31.8, indicating a trending market.
Overview
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
Finance Bot
Ask your questions
Start by typing a question below.
